Diamyd Therapeutics AB
4 clinical trials · Sponsor
◉ Watch Diamyd Therapeutics AB
| Record | Firm | Date |
|---|---|---|
| A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT (NCT00751842) | Diamyd Therapeutics AB | 2008-09-01 |
| A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU) (NCT00723411) | Diamyd Therapeutics AB | 2008-07-01 |
| Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes (NCT00435981) | Diamyd Therapeutics AB | 2005-01-01 |
| Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult) (NCT00456027) | Diamyd Therapeutics AB | 2004-12-01 |
Track Diamyd Therapeutics AB automatically
Every clearance here is in the API, with alerts when new ones post.